Trump’s Team Holds Back $140 Million in Fentanyl Fight: What It Means for America’s Drug Crisis

Admin

Trump’s Team Holds Back 0 Million in Fentanyl Fight: What It Means for America’s Drug Crisis

There’s a growing worry about the delay of around $140 million in federal grants meant for fighting fentanyl overdoses. Sources from the CDC revealed to NPR that these funds are critical for local and state health departments working to tackle rising overdose deaths.

One CDC staff member emphasized the stakes: “We’re talking about lives here. These delays could lead to shutdowns and layoffs in programs that are already stretched thin.” The CDC’s Overdose to Action (OD2A) program, which primarily targets overdose prevention, relies heavily on this funding.

Recent statistics paint a grim picture. In 2023, over 114,000 drug overdose deaths were reported, with fentanyl as a leading cause. The CDC credits the OD2A program with helping to reduce overdose deaths in previous years. According to Chrissie Juliano of the Big Cities Health Coalition, any cuts to this program’s funding would reverse this progress.

However, a bureaucratic tangle involving various government departments seems to be behind the funding hold-up. There’s confusion over criteria and processes required for releasing these vital funds. One CDC staffer noted, “We’re stuck in a slow-moving system, and the people who need help are paying the price.”

Moreover, experts warn that these funding delays could also affect drug surveillance programs crucial for detecting emerging dangers in the illicit drug market. Keith Humphreys, a drug policy researcher, stressed that not knowing what’s in street drugs puts the public at risk: “If we can’t monitor, we can’t warn.”

Dr. Benjamin Linas, an addiction researcher, highlighted the potential fallout, saying that many could lose access to necessary treatments. His research suggests that this could lead to an increase in overdose fatalities, countering the advancements made in drug treatment options.

As Congress deliberates potential cuts to addiction care and research programs, public health departments remain uncertain and anxious. They worry about the future of funding they depend on to save lives. While there’s still hope for the release of OD2A funds, the clock is ticking, and many programs are already halting new initiatives.



Source link